{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:30:13Z","timestamp":1787157013967,"version":"build-2736575974"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.metabol.2026.156717","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:12:08Z","timestamp":1785424328000},"page":"156717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diet and breast cancer: New perspectives on nutrition, metabolism, and immunity"],"prefix":"10.1016","volume":"183","author":[{"given":"Ru","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.metabol.2026.156717_bb0005","first-page":"477","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10074","key":"10.1016\/j.metabol.2026.156717_bb0010","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0015","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.7150\/ijbs.21635","article-title":"Risk factors and preventions of breast cancer","volume":"13","author":"Sun","year":"2017","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.metabol.2026.156717_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102852","article-title":"Estrogen signaling in early-stage breast cancer: impact on neoadjuvant chemotherapy and immunotherapy","volume":"132","author":"Corti","year":"2025","journal-title":"Cancer Treat Rev"},{"issue":"9869","key":"10.1016\/j.metabol.2026.156717_bb0025","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.metabol.2026.156717_bb0030","doi-asserted-by":"crossref","unstructured":"Ye F, Dewanjee S, Li Y, Jha NK, Chen Z, Kumar A, Vishakha, Behl T, Jha SK, Tang H. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. Mol Cancer 2023;22(1):105. doi:https:\/\/doi.org\/10.1186\/s12943-023-01805-y.","DOI":"10.1186\/s12943-023-01805-y"},{"key":"10.1016\/j.metabol.2026.156717_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","article-title":"Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets","volume":"60","author":"Liang","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156717_bb0040","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2026.156717_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104351","article-title":"Recent strategies to overcome breast cancer resistance","volume":"197","author":"Khan","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","article-title":"The great immune escape: understanding the divergent immune response in breast cancer subtypes","volume":"13","author":"Onkar","year":"2023","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.metabol.2026.156717_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103582","article-title":"Evidence update on the relationship between diet and the most common cancers from the European prospective investigation into cancer and nutrition (EPIC) study: a systematic review","volume":"13","author":"Ubago-Guisado","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clnu.2020.05.016","article-title":"Mediterranean-style dietary pattern improves cancer-related fatigue and quality of life in men with prostate cancer treated with androgen deprivation therapy: a pilot randomised control trial","volume":"40","author":"Baguley","year":"2021","journal-title":"Clinical nutrition (Edinburgh, Scotland)"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0065","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.clnu.2020.06.028","article-title":"Effects of ketogenic metabolic therapy on patients with breast cancer: a randomized controlled clinical trial","volume":"40","author":"Khodabakhshi","year":"2021","journal-title":"Clinical nutrition (Edinburgh, Scotland)"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0070","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41391-019-0126-5","article-title":"A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial","volume":"22","author":"Freedland","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188705","article-title":"Metabolic tricks of cancer cells","volume":"1877","author":"H\u00f6nigova","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.metabol.2026.156717_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the warburg effect supports aggressiveness and drug resistance of cancer cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0085","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.metabol.2026.156717_bb0090","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","article-title":"Emerging roles for branched-chain amino acid metabolism in cancer","volume":"37","author":"Sivanand","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s11658-022-00344-6","article-title":"The role of epigenetic modifications in drug resistance and treatment of breast cancer","volume":"27","author":"Karami Fath","year":"2022","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01178-1","article-title":"The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape","volume":"21","author":"Zipinotti Dos Santos","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"2","key":"10.1016\/j.metabol.2026.156717_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020089","article-title":"Metabolic reprogramming in breast cancer and its therapeutic implications","volume":"8","author":"Gandhi","year":"2019","journal-title":"Cells"},{"issue":"2\u20133","key":"10.1016\/j.metabol.2026.156717_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol Asp Med"},{"issue":"21","key":"10.1016\/j.metabol.2026.156717_bb0115","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-22-0800","article-title":"ALKBH5-mediated m6a demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.metabol.2026.156717_bb0120","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.21037\/tcr.2020.03.50","article-title":"GLUT1\/3\/4 as novel biomarkers for the prognosis of human breast cancer","volume":"9","author":"Zeng","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"22","key":"10.1016\/j.metabol.2026.156717_bb0125","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1158\/0008-5472.CAN-12-1098","article-title":"An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer","volume":"72","author":"Mccleland","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0130","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1038\/s41598-017-06378-7","article-title":"Tumor LDH-a expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis","volume":"7","author":"Dong","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.metabol.2026.156717_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002666","article-title":"KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase a (LDHA) and up-regulating h3k18 lactylation","volume":"22","author":"Hou","year":"2024","journal-title":"PLoS Biol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41419-022-04632-z","article-title":"Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"154634","key":"10.1016\/j.metabol.2026.156717_bb0145","article-title":"CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3k\/AKT\/HIF-1\u03b1 signaling","volume":"248","author":"Cao","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","article-title":"C-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"5","key":"10.1016\/j.metabol.2026.156717_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119716","article-title":"METTL3 orchestrates glycolysis by stabilizing the c-myc\/WDR5 complex in triple-negative breast cancer","volume":"1871","author":"Yuan","year":"2024","journal-title":"Biochim Biophys Acta (BBA) - Mol Cell Res"},{"issue":"8021","key":"10.1016\/j.metabol.2026.156717_bb0160","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0165","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41467-020-15308-7","article-title":"Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13337","article-title":"PFKFB4 facilitates palbociclib resistance in oestrogen receptor-positive breast cancer by enhancing stemness","volume":"56","author":"Wang","year":"2023","journal-title":"Cell Prolif"},{"issue":"4","key":"10.1016\/j.metabol.2026.156717_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.400","article-title":"Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer","volume":"11","author":"Lu","year":"2021","journal-title":"Clin Transl Med"},{"issue":"45","key":"10.1016\/j.metabol.2026.156717_bb0180","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/s41388-018-0386-x","article-title":"PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer","volume":"37","author":"Yang","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.metabol.2026.156717_bb0185","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbamcr.2019.03.004","article-title":"Lactate dehydrogenase a regulates autophagy and tamoxifen resistance in breast cancer","volume":"1866","author":"Das","year":"2019","journal-title":"Biochim Biophys Acta, Mol Cell Res"},{"issue":"28","key":"10.1016\/j.metabol.2026.156717_bb0190","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1038\/s41388-019-0817-3","article-title":"The mir-186-3p\/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells","volume":"38","author":"He","year":"2019","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.167011","article-title":"USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis","volume":"1870","author":"Gao","year":"2024","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"10.1016\/j.metabol.2026.156717_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216512","article-title":"The lipid metabolism remodeling: a hurdle in breast cancer therapy","volume":"582","author":"Xiao","year":"2024","journal-title":"Cancer Lett"},{"issue":"21","key":"10.1016\/j.metabol.2026.156717_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111881","article-title":"Adipose tissue-breast cancer crosstalk leads to increased tumor lipogenesis associated with enhanced tumor growth","volume":"22","author":"Micallef","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"32","key":"10.1016\/j.metabol.2026.156717_bb0210","doi-asserted-by":"crossref","first-page":"E6556","DOI":"10.1073\/pnas.1703791114","article-title":"CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation","volume":"114","author":"Wright","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.metabol.2026.156717_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110870","article-title":"Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids","volume":"39","author":"Li","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.metabol.2026.156717_bb0220","doi-asserted-by":"crossref","unstructured":"Ruidas B, Choudhury N, Chaudhury SS, Sur TK, Bhowmick S, Saha A, Das P, De P, Das Mukhopadhyay C. Precision targeting of fat metabolism in triple negative breast cancer with a biotinylated copolymer. J Mater Chem B 2025;13(4):1363\u201371. doi:https:\/\/doi.org\/10.1039\/d4tb02142h.","DOI":"10.1039\/D4TB02142H"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0225","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","article-title":"JAK\/STAT3-regulated fatty acid \u03b2-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156717_bb0230","doi-asserted-by":"crossref","unstructured":"Luo J, Yao J, Deng X, Zheng X, Jia M, Wang Y, Huang Y, Zhu J. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3k\/AKT signaling. J Exp Clin Cancer Res 2018;37(1):23. doi:https:\/\/doi.org\/10.1186\/s13046-018-0694-6.","DOI":"10.1186\/s13046-018-0694-6"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0235","doi-asserted-by":"crossref","first-page":"18239","DOI":"10.1038\/s41598-022-20976-0","article-title":"Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance","volume":"12","author":"Bhadwal","year":"2022","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.metabol.2026.156717_bb0240","article-title":"Unveiling alterations of epigenetic modifications and chromatin architecture leading to lipid metabolic reprogramming during the evolutionary trastuzumab adaptation of HER2-positive breast cancer","volume":"11","author":"Duan","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.metabol.2026.156717_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122763","article-title":"Low GPR81 in ER(+) breast cancer cells drives tamoxifen resistance through inducing PPAR\u03b1-mediated fatty acid oxidation","volume":"350","author":"Yu","year":"2024","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.metabol.2026.156717_bb0250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","article-title":"Metabolomic rewiring promotes endocrine therapy resistance in breast cancer","volume":"84","author":"Ahn","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2026.156717_bb0255","doi-asserted-by":"crossref","unstructured":"Bacci M, Lorito N, Smiriglia A, Subbiani A, Bonechi F, Comito G, Morriset L, El Botty R, Benelli M, L\u00f3pez-Velazco JI, et al. Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER(+) breast cancer. Sci Transl Med 2024;16(736):eadf9874. doi:https:\/\/doi.org\/10.1126\/scitranslmed.adf9874.","DOI":"10.1126\/scitranslmed.adf9874"},{"issue":"6","key":"10.1016\/j.metabol.2026.156717_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101004","article-title":"Differential expression of enzymes associated with serine\/glycine metabolism in different breast cancer subtypes","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molcel.2020.09.006","article-title":"Amino acids and their transporters in t cell immunity and cancer therapy","volume":"80","author":"Wang","year":"2020","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.metabol.2026.156717_bb0270","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.112.192344","article-title":"Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells","volume":"342","author":"Banerjee","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.metabol.2026.156717_bb0275","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.4161\/cbt.7.9.6282","article-title":"Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma","volume":"7","author":"Wlcek","year":"2008","journal-title":"Cancer Biol Ther"},{"issue":"10\u221211","key":"10.1016\/j.metabol.2026.156717_bb0280","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/00498250600861751","article-title":"Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition","volume":"36","author":"Bleasby","year":"2006","journal-title":"Xenobiotica"},{"issue":"12","key":"10.1016\/j.metabol.2026.156717_bb0285","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41568-021-00395-5","article-title":"Stress and cancer: mechanisms, significance and future directions","volume":"21","author":"Eckerling","year":"2021","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.metabol.2026.156717_bb0290","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41419-023-06200-5","article-title":"Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress","volume":"14","author":"Cui","year":"2023","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0295","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41598-020-80668-5","article-title":"L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism","volume":"11","author":"Sato","year":"2021","journal-title":"Sci Rep"},{"issue":"7755","key":"10.1016\/j.metabol.2026.156717_bb0300","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41586-019-1126-2","article-title":"LLGL2 rescues nutrient stress by promoting leucine uptake in ER(+) breast cancer","volume":"569","author":"Saito","year":"2019","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.metabol.2026.156717_bb0305","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1038\/onc.2017.32","article-title":"The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ER\u03b1-negative breast cancer","volume":"36","author":"Thewes","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.metabol.2026.156717_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156334","article-title":"Carboxylic acid metabolism in cancer: mechanisms, microenvironment interactions, and therapeutic opportunities","volume":"171","author":"Bian","year":"2025","journal-title":"Metab Clin Exp"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-026-00427-2","article-title":"Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities","volume":"7","author":"Yu","year":"2026","journal-title":"Mol Biomed"},{"issue":"156273","key":"10.1016\/j.metabol.2026.156717_bb0320","article-title":"Fatty acid metabolism: the crossroads in intestinal homeostasis and tumor","volume":"169","author":"Lu","year":"2025","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2026.156717_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102225","article-title":"DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolism","volume":"100","author":"Moskovich","year":"2025","journal-title":"Mol Metab"},{"issue":"350","key":"10.1016\/j.metabol.2026.156717_bb0330","first-page":"63","article-title":"Fasting enhances the efficacy of sorafenib in breast cancer via mitophagy mediated ROS-driven p53 pathway","volume":"229","author":"Li","year":"2025","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0335","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-cellbio-120420-094431","article-title":"The AMPK pathway: molecular rejuvenation of metabolism and mitochondria","volume":"41","author":"Malik","year":"2025","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.metabol.2026.156717_bb0340","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","article-title":"MTOR at the nexus of nutrition, growth, ageing and disease","volume":"21","author":"Liu","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2026.156717_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1324045","article-title":"Targeting MYC at the intersection between cancer metabolism and oncoimmunology","volume":"15","author":"Venkatraman","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0350","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41419-024-06446-7","article-title":"USP43 stabilizes c-myc to promote glycolysis and metastasis in bladder cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0355","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13046-025-03477-6","article-title":"Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1\u03b1 axis in hepatocellular carcinoma","volume":"44","author":"Liu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"issue":"156419","key":"10.1016\/j.metabol.2026.156717_bb0360","article-title":"Pancreas meets brain: \u03b2-hydroxybutyrate as a novel \u201c\u03b2-cellular\u201d metabolism therapy","volume":"174","author":"Lopa","year":"2026","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.metabol.2026.156717_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2023.107841","article-title":"Mediterranean diet for cancer prevention and survivorship","volume":"178","author":"Monllor-Tormos","year":"2023","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.metabol.2026.156717_bb0370","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2026.156717_bb0375","doi-asserted-by":"crossref","unstructured":"Fan G, Yu B, Tang L, Zhu R, Chen J, Zhu Y, Huang H, Zhou L, Liu J, Wang W, et al. TSPAN8(+) myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer. Sci Transl Med 2024;16(741):eadj5705. doi:https:\/\/doi.org\/10.1126\/scitranslmed.adj5705.","DOI":"10.1126\/scitranslmed.adj5705"},{"key":"10.1016\/j.metabol.2026.156717_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444533","article-title":"Epigenetic regulation of human FOXP3+ tregs: from homeostasis maintenance to pathogen defense","volume":"15","author":"Yue","year":"2024","journal-title":"Front Immunol"},{"issue":"21","key":"10.1016\/j.metabol.2026.156717_bb0385","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1158\/0008-5472.CAN-22-0654","article-title":"Therapeutic targeting of tumor-infiltrating regulatory t cells in breast cancer","volume":"82","author":"Fattori","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2026.156717_bb0390","doi-asserted-by":"crossref","unstructured":"Tharp KM, Kersten K, Maller O, Timblin GA, Stashko C, Canale FP, Menjivar RE, Hayward M, Berestjuk I, Ten Hoeve J, et al. Tumor-associated macrophages restrict CD8(+) t cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Natl Cancer Inst Monogr 2024;5(7):1045\u201362. doi:https:\/\/doi.org\/10.1038\/s43018-024-00775-4.","DOI":"10.1038\/s43018-024-00775-4"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0395","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymthe.2020.09.034","article-title":"Olaparib suppresses MDSC recruitment via SDF1\u03b1\/CXCR4 axis to improve the anti-tumor efficacy of CAR-t cells on breast cancer in mice","volume":"29","author":"Sun","year":"2021","journal-title":"Molecular therapy\u202f: the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.metabol.2026.156717_bb0400","doi-asserted-by":"crossref","unstructured":"Zhao Y, Liu Z, Liu G, Zhang Y, Liu S, Gan D, Chang W, Peng X, Sung ES, Gilbert K, et al. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. Cell Metab 2023;35(10):1688\u2013703. doi:https:\/\/doi.org\/10.1016\/j.cmet.2023.09.004.","DOI":"10.1016\/j.cmet.2023.09.004"},{"key":"10.1016\/j.metabol.2026.156717_bb0405","doi-asserted-by":"crossref","unstructured":"Zappasodi R, Serganova I, Cohen IJ, Maeda M, Shindo M, Senbabaoglu Y, Watson MJ, Leftin A, Maniyar R, Verma S, et al. CTLA-4 blockade drives loss of t(reg) stability in glycolysis-low tumours. Nature 2021;591(7851):652\u20138. doi:https:\/\/doi.org\/10.1038\/s41586-021-03326-4.","DOI":"10.1038\/s41586-021-03326-4"},{"issue":"8","key":"10.1016\/j.metabol.2026.156717_bb0410","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202502538RR","article-title":"Lactate activates TGF-\u03b2\/SNAIL signaling to drive m2 macrophage polarization and CD8(+) t cell exhaustion in breast cancer","volume":"40","author":"Zhu","year":"2026","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-026-03063-5","article-title":"Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer","volume":"12","author":"Ielpo","year":"2026","journal-title":"Cell Death Discov"},{"issue":"12","key":"10.1016\/j.metabol.2026.156717_bb0420","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.cmet.2022.11.003","article-title":"Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells","volume":"34","author":"Gong","year":"2022","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116526","article-title":"Cancer-associated adipocytes mediate CD8(+)t cell dysfunction via FGF21-driven lipolysis","volume":"44","author":"Dalangood","year":"2025","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.metabol.2026.156717_bb0430","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.7150\/ijbs.113213","article-title":"Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer","volume":"21","author":"Zeng","year":"2025","journal-title":"Int J Biol Sci"},{"issue":"4","key":"10.1016\/j.metabol.2026.156717_bb0435","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140100","article-title":"Selective glutamine metabolism inhibition in tumor cells improves antitumor t lymphocyte activity in triple-negative breast cancer","volume":"131","author":"Edwards","year":"2021","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0440","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/cac2.12608","article-title":"Tryptophan 2,3-dioxygenase-positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine-mediated ferroptosis resistance of metastatic cells and t cell dysfunction","volume":"44","author":"Liu","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.metabol.2026.156717_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155326","article-title":"Body fatness associations with cancer: evidence from recent epidemiological studies and future directions","volume":"137","author":"Larsson","year":"2022","journal-title":"Metab Clin Exp"},{"issue":"16","key":"10.1016\/j.metabol.2026.156717_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/nu16162644","article-title":"Nutrition intervention and microbiome modulation in the management of breast cancer","volume":"16","author":"Jiang","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0455","article-title":"Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential","volume":"9","author":"Xiao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.metabol.2026.156717_bb0460","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.cmet.2024.06.013","article-title":"International consensus on fasting terminology","volume":"36","author":"Koppold","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2026.156717_bb0465","article-title":"Intermittent fasting inhibits the development of colorectal cancer in APC (min\/+) mice through gut microbiota and its related metabolites","volume":"16","author":"Chen","year":"2025","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.metabol.2026.156717_bb0470","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gutjnl-2024-333020","article-title":"Fasting-mimicking diet-enriched bifidobacterium pseudolongum suppresses colorectal cancer by inducing memory CD8(+) t cells","volume":"74","author":"Nan","year":"2025","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.metabol.2026.156717_bb0475","doi-asserted-by":"crossref","first-page":"e953","DOI":"10.1212\/WNL.0000000000012386","article-title":"Feasibility and biological activity of a ketogenic\/intermittent-fasting diet in patients with glioma","volume":"97","author":"Schreck","year":"2021","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0480","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13507","article-title":"Innate immune remodeling by short-term intensive fasting","volume":"20","author":"Qian","year":"2021","journal-title":"Aging Cell"},{"issue":"7817","key":"10.1016\/j.metabol.2026.156717_bb0485","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","article-title":"Fasting-mimicking diet and hormone therapy induce breast cancer regression","volume":"583","author":"Caffa","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2026.156717_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101161","article-title":"Fasting-mimicking diet potentiates anti-tumor effects of CDK4\/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling","volume":"78","author":"Li","year":"2025","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0495","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12967-023-03935-9","article-title":"Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming","volume":"21","author":"Pateras","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.metabol.2026.156717_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115699","article-title":"Verification of fasting-mimicking diet to assist monotherapy of human cancer-bearing models","volume":"215","author":"Huang","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0505","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.cmet.2021.10.008","article-title":"Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape","volume":"33","author":"Salvadori","year":"2021","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0510","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1186\/s12967-023-04577-7","article-title":"Fasting mimicking diet inhibits tumor-associated macrophage survival and pro-tumor function in hypoxia: implications for combination therapy with anti-angiogenic agent","volume":"21","author":"Wang","year":"2023","journal-title":"J Transl Med"},{"issue":"10","key":"10.1016\/j.metabol.2026.156717_bb0515","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1002\/fsn3.2510","article-title":"Intermittent fasting suppressed splenic CD205+ g-MDSC accumulation in a murine breast cancer model by attenuating cell trafficking and inducing apoptosis","volume":"9","author":"Fu","year":"2021","journal-title":"Food Sci Nutr"},{"issue":"20","key":"10.1016\/j.metabol.2026.156717_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204357","article-title":"Ketogenic diet and breast cancer: recent findings and therapeutic approaches","volume":"15","author":"Urz\u00ec","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.metabol.2026.156717_bb0525","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.3390\/curroncol30040320","article-title":"High-fat diet exposure in early life alters mammary metabolic and inflammatory microenvironment in favor of breast tumorigenesis later in life in mice","volume":"30","author":"Tang","year":"2023","journal-title":"Current oncology (Toronto, Ont)"},{"issue":"24","key":"10.1016\/j.metabol.2026.156717_bb0530","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1158\/0008-5472.CAN-25-0822","article-title":"An olive oil-based high-fat diet promotes obesity-driven metastasis of triple-negative breast cancer","volume":"85","author":"Avellino","year":"2025","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.metabol.2026.156717_bb0535","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0540","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.cmet.2024.09.013","article-title":"Adipocyte-derived glutathione promotes obesity-related breast cancer by regulating the SCARB2-ARF1-mTORC1 complex","volume":"37","author":"Zhao","year":"2025","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0545","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.6452","article-title":"High-fat diets influence breast cancer progression by modulating CAF-immune cell interactions through PLAT signaling","volume":"267","author":"Li","year":"2025","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0550","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40170-024-00339-1","article-title":"Metabolic alterations and cellular responses to \u03b2-hydroxybutyrate treatment in breast cancer cells","volume":"12","author":"Fulman-Levy","year":"2024","journal-title":"Cancer Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41523-024-00715-6","article-title":"Co-targeting of metabolism using dietary and pharmacologic approaches reduces breast cancer metastatic burden","volume":"11","author":"Zuo","year":"2025","journal-title":"NPJ Breast Cancer"},{"issue":"12","key":"10.1016\/j.metabol.2026.156717_bb0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233662","article-title":"The effect of a ketogenic diet and synergy with rapamycin in a mouse model of breast cancer","volume":"15","author":"Zou","year":"2020","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0565","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.molcel.2021.03.037","article-title":"Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade","volume":"81","author":"Dai","year":"2021","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.metabol.2026.156717_bb0570","article-title":"Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation","volume":"6","author":"Bartmann","year":"2018","journal-title":"Cancer Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0575","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-025-00385-3","article-title":"Ketomimetic nutrients remodel the glycocalyx and trigger a metabolic defense in breast cancer cells","volume":"13","author":"Kamra","year":"2025","journal-title":"Cancer Metab"},{"key":"10.1016\/j.metabol.2026.156717_bb0580","doi-asserted-by":"crossref","unstructured":"Mashinchian M, Vandghanooni S, Karamibonari AR, Eskandani M. \u0392-hydroxybutyrate promotes chemoresistance and proliferation in breast cancer cells. Biochem Biophys Rep 2025;44(102217. doi:https:\/\/doi.org\/10.1016\/j.bbrep.2025.102217.","DOI":"10.1016\/j.bbrep.2025.102217"},{"issue":"14","key":"10.1016\/j.metabol.2026.156717_bb0585","first-page":"34","article-title":"Clinical and molecular aspects of breast cancer: targets and therapies","volume":"106","author":"Godone","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.metabol.2026.156717_bb0590","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.7150\/ijbs.109803","article-title":"Targeting glycolysis for treatment of breast cancer resistance: current progress and future prospects","volume":"21","author":"Niu","year":"2025","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.metabol.2026.156717_bb0595","doi-asserted-by":"crossref","unstructured":"Zhang J, Wu Y, Li Y, Li S, Liu J, Yang X, Xia G, Wang G. Natural products and derivatives for breast cancer treatment: from drug discovery to molecular mechanism. Phytomedicine 2024;129(155600. doi:https:\/\/doi.org\/10.1016\/j.phymed.2024.155600.","DOI":"10.1016\/j.phymed.2024.155600"},{"issue":"100","key":"10.1016\/j.metabol.2026.156717_bb0600","first-page":"11","article-title":"Triple-negative breast cancer therapeutic resistance: where is the achilles\u2019 heel?","volume":"497","author":"Bai","year":"2021","journal-title":"Cancer Lett"},{"issue":"17","key":"10.1016\/j.metabol.2026.156717_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179644","article-title":"New advances in the research of resistance to neoadjuvant chemotherapy in breast cancer","volume":"22","author":"An","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156717_bb0610","doi-asserted-by":"crossref","unstructured":"Shi J, Li J, Li J, Li R, Wu X, Gao F, Zou L, Mak WWS, Fu C, Zhang J, et al. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor. Phytomedicine 2021;81(153408. doi:https:\/\/doi.org\/10.1016\/j.phymed.2020.153408.","DOI":"10.1016\/j.phymed.2020.153408"},{"issue":"24","key":"10.1016\/j.metabol.2026.156717_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413416","article-title":"Epigenetic and cellular reprogramming of doxorubicin-resistant MCF-7 cells treated with curcumin","volume":"25","author":"Poma","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.metabol.2026.156717_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/nu15071658","article-title":"Docosahexaenoic acid, a key compound for enhancing sensitization to drug in doxorubicin-resistant MCF-7 cell line","volume":"15","author":"Crovella","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0625","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/ptr.7388","article-title":"The natural isoflavone biochanin-a synergizes 5-fluorouracil anticancer activity in vitro and in vivo in ehrlich solid-phase carcinoma model","volume":"36","author":"Mahmoud","year":"2022","journal-title":"Phytotherapy research\u202f: PTR"},{"key":"10.1016\/j.metabol.2026.156717_bb0630","doi-asserted-by":"crossref","unstructured":"Mitra D, Saha D, Das G, Mukherjee R, Banerjee S, Alam N, Mustafi SM, Nath P, Majumder A, Majumder B, et al. Lupeol synergizes with 5-fluorouracil to combat c-MET\/EphA2 mediated chemoresistance in triple negative breast cancer iScience 2023;26(12):108395. doi:https:\/\/doi.org\/10.1016\/j.isci.2023.108395.","DOI":"10.1016\/j.isci.2023.108395"},{"key":"10.1016\/j.metabol.2026.156717_bb0635","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/DDDT.S390602","article-title":"10-gingerol enhances the effect of taxol in triple-negative breast cancer via targeting ADRB2 signaling","volume":"17","author":"Liang","year":"2023","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.metabol.2026.156717_bb0640","doi-asserted-by":"crossref","unstructured":"Luo B, Song L, Chen L, Cai Y, Zhang M, Wang S. Ganoderic acid d attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting glycolysis via HIF-1\u03b1 destabilization. Phytomedicine 2024;129(155675. doi:https:\/\/doi.org\/10.1016\/j.phymed.2024.155675.","DOI":"10.1016\/j.phymed.2024.155675"},{"issue":"10","key":"10.1016\/j.metabol.2026.156717_bb0645","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400261","article-title":"Functional combination of resveratrol and tamoxifen to overcome tamoxifen-resistance in breast cancer cells","volume":"357","author":"Radwan","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"issue":"5","key":"10.1016\/j.metabol.2026.156717_bb0650","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1142\/S0192415X20500603","article-title":"MLL3 induced by luteolin causes apoptosis in tamoxifen-resistant breast cancer cells through H3K4 monomethylation and suppression of the PI3K\/AKT\/mTOR pathway","volume":"48","author":"Wu","year":"2020","journal-title":"Am J Chin Med"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0655","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.577","article-title":"Baicalein resensitizes tamoxifen-resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia-inducible factor-1\u03b1","volume":"11","author":"Chen","year":"2021","journal-title":"Clin Transl Med"},{"issue":"5","key":"10.1016\/j.metabol.2026.156717_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052887","article-title":"Glyceollins trigger anti-proliferative effects in hormone-dependent aromatase-inhibitor-resistant breast cancer cells through the induction of apoptosis","volume":"23","author":"Walker","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156717_bb0665","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jare.2024.04.010","article-title":"Urolithin A inhibits breast cancer progression via activating TFEB-mediated mitophagy in tumor macrophages","volume":"69","author":"Zheng","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.metabol.2026.156717_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115808","article-title":"Scutellarin suppresses the metastasis of triple-negative breast cancer via targeting TNF\u03b1\/TNFR2-RUNX1-triggered g-CSF expression in endothelial cells","volume":"217","author":"Mei","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0675","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"10.1016\/j.metabol.2026.156717_bb0680","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23147659","article-title":"Endothelium-dependent induction of vasculogenic mimicry in human triple-negative breast cancer cells is inhibited by calcitriol and curcumin","volume":"23","author":"Morales-Guadarrama","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2026.156717_bb0685","doi-asserted-by":"crossref","unstructured":"Yang B, Luo J, Wang J, Zhang J, Zheng Y, Wang S, Wang N, Wang Z. Liquiritin in aiduqing formula inhibits breast cancer neoangiogenesis by suppressing CTSK-mediated lysosomal degradation of CXCL1 in tumor-associated macrophages. Phytomedicine 2025;148(157358. doi:https:\/\/doi.org\/10.1016\/j.phymed.2025.157358.","DOI":"10.1016\/j.phymed.2025.157358"},{"issue":"2","key":"10.1016\/j.metabol.2026.156717_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2025.102809","article-title":"Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies","volume":"36","author":"Luzarraga Aznar","year":"2026","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.metabol.2026.156717_bb0695","doi-asserted-by":"crossref","first-page":"H1508","DOI":"10.1152\/ajpheart.00377.2025","article-title":"Chemotherapy-induced cardiotoxicity in breast cancer: mechanisms, diagnostic advances, and emerging protective strategies","volume":"329","author":"Ndzie Noah","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"10.1016\/j.metabol.2026.156717_bb0700","first-page":"1171","article-title":"The novel combination of astragaloside IV and formononetin protects from doxorubicin-induced cardiomyopathy by enhancing fatty acid metabolism","volume":"23","author":"Yu","year":"2025","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.metabol.2026.156717_bb0705","doi-asserted-by":"crossref","unstructured":"Cheng Y, Wu X, Nie X, Wu Y, Zhang C, Lee SM, Lv K, Leung GP, Fu C, Zhang J, et al. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2\/HO-1 signaling pathway. Phytomedicine 2022;106(154407. doi:https:\/\/doi.org\/10.1016\/j.phymed.2022.154407.","DOI":"10.1016\/j.phymed.2022.154407"},{"key":"10.1016\/j.metabol.2026.156717_bb0710","doi-asserted-by":"crossref","unstructured":"Jiang Y, Zhao B, Jiang P, Wang S, Ma L, Wu G, Wang M, Sun H. Raspberry ketone alleviates radiation-induced lung injury through the STAT2-p2x7r\/NLRP3 signaling pathway. Phytomedicine 2025;145(156984. doi:https:\/\/doi.org\/10.1016\/j.phymed.2025.156984.","DOI":"10.1016\/j.phymed.2025.156984"},{"issue":"3","key":"10.1016\/j.metabol.2026.156717_bb0715","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1039\/D2FO02198F","article-title":"One-year nutrition counselling in the context of a mediterranean diet reduced the dietary inflammatory index in women with breast cancer: a role for the dietary glycemic index","volume":"14","author":"Vitale","year":"2023","journal-title":"Food Funct"},{"key":"10.1016\/j.metabol.2026.156717_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123855","article-title":"Elucidating the effect of the Mediterranean diet on fecal bile acids and their mediating role on biomarkers of intestinal barrier function: an exploratory analysis of a randomized controlled trial","volume":"379","author":"Seethaler","year":"2025","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.metabol.2026.156717_bb0725","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/01635581.2023.2192891","article-title":"Barriers and facilitators to adherence to a mediterranean diet intervention during chemotherapy treatment: a qualitative analysis","volume":"75","author":"Harvey","year":"2023","journal-title":"Nutr Cancer"},{"issue":"7","key":"10.1016\/j.metabol.2026.156717_bb0730","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00394-023-03172-2","article-title":"Omega-3 polyunsaturated fatty acids improve intestinal barrier integrity-albeit to a lesser degree than short-chain fatty acids: an exploratory analysis of the randomized controlled LIBRE trial","volume":"62","author":"Seethaler","year":"2023","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.metabol.2026.156717_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation","volume":"12","author":"Gasaly","year":"2021","journal-title":"Front Immunol"},{"issue":"122612","key":"10.1016\/j.metabol.2026.156717_bb0740","article-title":"Gut microbiota as a key regulator of intestinal mucosal immunity","volume":"345","author":"Wang","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2026.156717_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.103983","article-title":"Immunogenic cell death: a link between gut microbiota and anticancer effects","volume":"141","author":"Chen","year":"2020","journal-title":"Microb Pathog"},{"issue":"23","key":"10.1016\/j.metabol.2026.156717_bb0750","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0755","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12282-025-01782-8","article-title":"Characterization of gut microbiota dysbiosis in breast cancer patients","volume":"33","author":"Yamada","year":"2026","journal-title":"Breast cancer (Tokyo, Japan)"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0760","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1038\/s41598-025-89801-8","article-title":"Correlation between gut microbiota dysbiosis, metabolic syndrome and breast cancer","volume":"15","author":"Abdelqader","year":"2025","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.metabol.2026.156717_bb0765","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-20-1659","article-title":"Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer","volume":"81","author":"Di Modica","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.metabol.2026.156717_bb0770","doi-asserted-by":"crossref","unstructured":"Schettini F, Fontana A, Gattazzo F, Strina C, Milani M, Cappelletti MR, Cervoni V, Morelli L, Curigliano G, Iebba V, et al. Faecal microbiota composition is related to response to CDK4\/6-inhibitors in metastatic breast cancer: a prospective cross-sectional exploratory study. European journal of cancer (Oxford, England : 1990) 2023;191(112948. doi:https:\/\/doi.org\/10.1016\/j.ejca.2023.112948.","DOI":"10.1016\/j.ejca.2023.112948"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0775","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2610077","article-title":"Tamoxifen induced hepatotoxicity via gut microbiota-mediated hyodeoxycholic acid depletion and farnesoid x receptor signaling disruption","volume":"18","author":"Chen","year":"2026","journal-title":"Gut Microbes"},{"key":"10.1016\/j.metabol.2026.156717_bb0780","doi-asserted-by":"crossref","unstructured":"Otto-Dobos LD, Grant CV, Lahoud AA, Wilcox OR, Strehle LD, Loman BR, Adarkwah Yiadom S, Seng MM, Halloy NR, Russart KLG, et al. Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer. Brain Behav Immun 2024;120(208-20. doi:https:\/\/doi.org\/10.1016\/j.bbi.2024.05.039.","DOI":"10.1016\/j.bbi.2024.05.039"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0785","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/cncr.35229","article-title":"Gut microbiome in association with chemotherapy-induced toxicities among patients with breast cancer","volume":"130","author":"Nguyen","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.metabol.2026.156717_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2026.106489","article-title":"Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and pain","volume":"135","author":"Beales","year":"2026","journal-title":"Brain Behav Immun"},{"issue":"21","key":"10.1016\/j.metabol.2026.156717_bb0795","doi-asserted-by":"crossref","DOI":"10.3390\/nu15214628","article-title":"Association between gut microbiota and breast cancer: diet as a potential modulating factor","volume":"15","author":"Altinok Dindar","year":"2023","journal-title":"Nutrients"},{"issue":"101222","key":"10.1016\/j.metabol.2026.156717_bb0800","article-title":"The combination of flaxseed lignans and PD-1\/ PD-l1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity","volume":"80","author":"Wu","year":"2025","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.metabol.2026.156717_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119723","article-title":"Huaier enhances the antitumor effects of CDK 4\/6 inhibitor by remodeling the immune microenvironment and gut microbiota in breast cancer","volume":"347","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"10.1016\/j.metabol.2026.156717_bb0810","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.cell.2025.04.041","article-title":"Microbiome metabolism of dietary phytochemicals controls the anticancer activity of PI3k inhibitors","volume":"188","author":"Roichman","year":"2025","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0815","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1186\/s12967-024-05843-y","article-title":"Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of triple negative breast cancer","volume":"22","author":"Gong","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.metabol.2026.156717_bb0820","article-title":"Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.metabol.2026.156717_bb0825","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s12905-025-04039-w","article-title":"Lactate dehydrogenase a is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer","volume":"25","author":"Xia","year":"2025","journal-title":"BMC Womens Health"},{"issue":"8098","key":"10.1016\/j.metabol.2026.156717_bb0830","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41586-025-09869-0","article-title":"Fasting boosts breast cancer therapy efficacy via glucocorticoid activation","volume":"649","author":"Padr\u00e3o","year":"2026","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.metabol.2026.156717_bb0835","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.clnu.2021.01.023","article-title":"A ketogenic diet consumed during radiotherapy improves several aspects of quality of life and metabolic health in women with breast cancer","volume":"40","author":"Klement","year":"2021","journal-title":"Clinical nutrition (Edinburgh, Scotland)"},{"issue":"14","key":"10.1016\/j.metabol.2026.156717_bb0840","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147517","article-title":"Immunotherapy in breast cancer","volume":"25","author":"Dvir","year":"2024","journal-title":"Int J Mol Sci"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:00:56Z","timestamp":1787155256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526002301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":168,"alternative-id":["S0026049526002301"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156717","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diet and breast cancer: New perspectives on nutrition, metabolism, and immunity","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156717"}}